2023 Was a tricky calendar year with the biopharma field, with many businesses downsizing and restructuring their workforces to stay afloat. You will find signs of recovery, as mergers and acquisitions picked up across the pharmaceutical and daily life sciences marketplace in the latter A part of 2023 and have https://sites.google.com/view/bio-sites/blog